Celularity Inc. Class A Common Stock (CELU)

Health Care·equity

$1.56

+6.85% today

Extended hours $1.59

Prices delayed about 15 minutes · cached page, can be an hour old or more

Market Census Score

65/ 100

Score level

Above average

5 of 6 checks had data

How it compares with the broader market is one of its highest-scoring factors; business numbers score is on the low side, price trend score is near the top of its range.

CELU scores higher than 92% of the 1,101 tickers we compare it with (Health Care).

As of 9 October 2026, Celularity Inc. Class A Common Stock (CELU) scores 65 out of 100 on the Market Census six-factor composite, which puts it at the Above average score level. The score is made from six named factors: price trend, strength vs the market, company finances, insider trades, market mood and recent momentum. It records what they read on 9 October 2026, and it is not investment advice.

Updated 9 October 2026 · scores usually change about once a day

Key statistics

Market fields as reported. An em-dash means we hold no value for this ticker — most of the universe has no daily price or volume read.

Relative volume: 0.06× 30-day average
52-week range: 0.56 – 2.55
Market cap: $37.92M
Earnings date: 12 Nov 2026

Volume: 53,190
Avg. volume (30d): 845,573

Open: 1.46
Previous close: 1.46
Day's range (regular session): 1.45 – 1.57

The last trade can be an extended-hours trade, so it can sit outside the regular-session range.

Shown without a peer ranking — we hold no percentile for these yet, so there is nothing here to locate them against.

Beta: 0.85
P/E (TTM): —
EPS (TTM): -3.59

Score breakdown · six named factors

Price trend

Strength vs the market

100

Company finances

Insider trades

—

Market mood

Recent momentum

Each bar is one part of the score, from 0 to 100. Read what the score means.

What the score says about CELU right now

Celularity Inc. Class A Common Stock (CELU) currently scores 65/100 on the Market Census six-factor composite, at the Above average score level. CELU is +6.85% on the day and -2.50% over five sessions as of the most recent tick. Above average sits a bit above the middle. The data for CELU leans good, with some weak spots. CELU's strongest factor is strength vs the market at 100/100 — a very strong read on how CELU has done next to the wider market. It describes what has happened, not what happens next. The weakest factor is company finances at 0/100 — well below average company numbers. A low company-finances reading is the canonical "value trap" warning: technical setups on broken fundamentals don't tend to compound.

Generated from the six-factor breakdown above. Changes when the underlying scores do, usually about once a day. More on what the score means.

See CELU in the scanner

This page is free to read with no account at all. Signing up takes an email and a password: a free account runs the scanner on the top 10 scored rows of any scan, keeps one saved screen, a 5-ticker watchlist, and opens 12 ticker detail pages a day. The card is what starts a 30-day Premium trial — $0 that day, then $19.99/month from day 30, cancel online any time before then — and that is what turns on every matching row instead of the first 10, alerts, the 200-ticker watchlist and recent insider buys (SEC Form 4).

Create your account →Share on X Embed this score